Co-Authors
This is a "connection" page, showing publications co-authored by Giustino Parruti and Marcello Di Nisio.
Connection Strength
1.124
-
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19. Eur J Intern Med. 2021 01; 83:34-38.
Score: 0.228
-
Response to: 'Correspondence on 'Interleukin-6 blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study' by Potere et al' by Buckley. Ann Rheum Dis. 2020 Sep 01.
Score: 0.225
-
Low-dose subcutaneous tocilizumab to prevent disease progression in patients with moderate COVID-19 pneumonia and hyperinflammation. Int J Infect Dis. 2020 Nov; 100:421-424.
Score: 0.224
-
Response to: 'Rational use of tocilizumab in COVID-19' by Jain and Sharma. Ann Rheum Dis. 2020 Jul 31.
Score: 0.224
-
Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study. Ann Rheum Dis. 2021 02; 80(2):1-2.
Score: 0.223